C.M. Bidwell & Associates’s Axonics, Inc. Common Stock AXNX Stock Holding History

C.M. Bidwell & Associates’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,213	Closed	-$75.5K	–	558
2023 Q4	$75.5K	Sell	1,213 -57	-4%	-$3.19K	0.06%	186
2023 Q3	$71.3K	Buy	1,270 +660	+108%	+$37.1K	0.05%	264
2023 Q2	$30.8K	Buy	+610	New	+$32.5K	0.02%	335

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

C.M. Bidwell & Associates's AXNX Position: Q1 2024 in Review

C.M. Bidwell & Associates sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 1,213 shares — an estimated $75.5K sold.

C.M. Bidwell & Associates first reported a position in AXNX in Q2 2023 and held it in 3 quarters. The position peaked at $75.5K in Q4 2023. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

C.M. Bidwell & Associates reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
C.M. Bidwell & Associates sold 1,213 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $75.5K.
C.M. Bidwell & Associates first reported a position in Axonics, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
C.M. Bidwell & Associates's Axonics, Inc. Common Stock position peaked at $75.5K in Q4 2023.
235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2024, filed 14 May 2024.